These drugs are the latest in a growing list of oncology medications in short supply:
Azacitidine injections: Three drugmakers stopped making 100 milligram solutions of the leukemia drug.
Iobenguane I-131 injections: Progenics Pharmaceuticals stopped making two solutions because of low demand for the oncology medication.
